Ashwin Balagopal, MD

• Chair, ACTG 5335s
• Investigator ACTG 5329 and ACTG 5334s
• Investigator, Hepatitis Transformative Science Group (Feb 2016)

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...

An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...

Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...

Johns Hopkins University Baltimore-India Clinical Trials Unit